Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2003
06/11/2003EP0973741B1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
06/11/2003EP0950053B1 New derivatives of benzoylalkyl-1,2,3,6-tetrahydropyridins
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals
06/11/2003CN1423630A Quaternary ammonium compounds and their use as anti-tussive agents
06/11/2003CN1422852A Substituted hexa azacylo compounds and their use as neuroregulator
06/11/2003CN1111157C Preparation of 2,2,6,6-tetraalkyl-4-piperylhydrazines
06/10/2003US6576791 Local anesthetic compounds and uses
06/10/2003US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt
06/10/2003US6576650 No central nervous system side effects
06/10/2003US6576646 Administering cholinesterase inhibitor
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045917A2 Ccr-3 receptor antagonists vii
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003US20030105329 Process for the production of piperidine derivatives
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105134 Using diaroyltartaric acid as resolution agent; isomer purity; attention deficit disorders
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105131 Aids therapy; antiinflamamtory agents; antiallergens; rheumatic diseases
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105079 Novel phenylalkyl diamine and amide analogs
06/05/2003US20030105072 Compounds, compositions, and methods for controlling biofilms
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2467874A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/04/2003EP1315701A1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine
06/04/2003EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
06/04/2003EP1315495A2 Use of threo-methylphenidate compounds to enhance memory
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
06/04/2003EP1131289A4 Processes for preparing 2-piperidineethanol compounds
06/04/2003EP1114027B1 The preparation of n-substituted-hydroxycycloalkylamine derivatives
06/04/2003EP1062358B1 Novel method for preparing fexofenadine
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
06/04/2003EP0804417B1 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
06/04/2003CN1422156A Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
06/04/2003CN1421434A Prepn process of nifedipine
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110479C Production of 1-chlorocarbonyl-4-piperidinopieridine or hydrochloride thereof
06/04/2003CN1110478C Biocidal benzylbiphenyl derivatives
06/03/2003US6573384 Process for production of indole derivatives and intermediates therefor
06/03/2003US6573346 Telechelics based on vinyl polymers using a functionalized alkoxyamine initiator
06/03/2003US6573281 Its pharmaceutically acceptable salts for the treatment or prevention of adaptation disorders, bipolar disorders, and dysthymic disorders.
05/2003
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003044012A1 N-formyl derivatives of paroxetine
05/30/2003WO2003043989A1 Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043987A2 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003WO2003043635A1 Amlodipine salt forms and processes for preparing them
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2002062885A3 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds
05/30/2003WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467749A1 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2464327A1 N-formyl derivatives of paroxetine
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100750 Process for solid supported synthesis of pyruvate-derived compounds
05/29/2003US20030100681 Crosslinkable monomers for novel nonlinear optical polymers
05/29/2003US20030100561 Treatment of insulin resistance with growth hormone secretagogues
05/29/2003US20030100547 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
05/29/2003US20030100532 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/29/2003US20030100018 Mass-based encoding and qualitative analysis of combinatorial libraries
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313703A1 Prodrugs to nmda receptor ligands
05/28/2003EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP0971713B1 Use of cholinesterase inhibitors to treat disorders of attention
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420871A 4-formyl amino-N- methylpiperidine derivs., use thereof as stabilisers and organic material stabilised therewith
05/28/2003CN1420870A Modulators of dopamine neurotransmission
05/28/2003CN1420869A Modulators of dopamine neurotransmission
05/27/2003US6570038 Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use
05/27/2003US6570018 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
05/27/2003US6569861 Melanin concentrating hormone receptor ligands
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569849 N-Substituted azaheterocyclic compounds
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists